These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27919349)

  • 1. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.
    Ellis KL; Pang J; Chieng D; Bell DA; Burnett JR; Schultz CJ; Hillis GS; Watts GF
    Clin Cardiol; 2018 Mar; 41(3):378-384. PubMed ID: 29480541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia.
    Mateo-Gallego R; Perez-Calahorra S; Cofán M; Baila-Rueda L; Cenarro A; Ros E; Puzo J; Civeira F
    J Nutr; 2014 Aug; 144(8):1219-26. PubMed ID: 24899155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
    Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
    J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia].
    Pei WD; Sun YH; Rou WJ; Zu Q; Li Y; Zhang CY; Dai J; Jia YH; Lu ZL; Wu XG; Liu LS; Hui RT
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):313-7. PubMed ID: 15854507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.
    Pei WD; Sun YH; Lu B; Liu Q; Zhang CY; Zhang J; Jia YH; Lu ZL; Hui RT; Liu LS; Yang YJ
    Int J Cardiol; 2007 Mar; 116(2):194-200. PubMed ID: 16828905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) serum concentration in familial combined hyperlipidemia.
    Fonda M; Da Col PG; La Verde R; Battello C; Fisicaro M; Tonizzo M; Cattin L
    Clin Chim Acta; 1993 Dec; 223(1-2):121-7. PubMed ID: 8143358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia.
    Pei WD; Sun YH; Liu Q; Zheng WY; Zhang J; Zhang CY; Gong J; Hopkins PN; Hui RT; Liu LS; Yang YJ
    Int J Cardiol; 2007 Feb; 115(3):293-6. PubMed ID: 16797745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome.
    Jubran A; Zetser A; Zafrir B
    Cardiol J; 2019; 26(5):511-518. PubMed ID: 30234895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein(a) in heterozygote familial hypercholesterolemia].
    Ochoa Sosa CA; Zamora González J; González Hermosillo JA; Ize Lema I; Cardoso Saldaña G; Posadas Romero C
    Arch Inst Cardiol Mex; 1994; 64(6):549-55. PubMed ID: 7726691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
    Tada H; Kawashiri MA; Yoshida T; Teramoto R; Nohara A; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Circ J; 2016; 80(2):512-8. PubMed ID: 26632531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].
    Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F
    Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.